I think this little bit of news slipped out on a Friday afternoon could be setting up the rewards for management prior to news. IMHO
Considering that Dr. Jan-Anders Karlsson already holds 92,400 Ordinary Shares, representing 0.09% of the Company's issued share capital the issue of such a large number of various option at about the current share price seems to underline for me the fact that the current share price is probably now the base.
One cannot help thinking that a swift and exponential rise is on the way. IMHO
Another piece of strong evidence that we are onto a effective and more importantly, from a shareholder perspective, commercially viable product/products.
The big pharma's are always trying to bolster up there portfolios and my guess is we'll see a move for VRP sooner or later. The NASDAQ listing looks like being being a clever move raising the profile of the Company in the US, probably the worlds major market for the drugs, where premium priced products can be prescribed and paid for.
Existing holders are going to hang on to their shares so it is likely that the share price will be moved upwards to generate some liquidity. IMHO.
Tempting as it will be, if this proves to be the case, I will resist the urge to 'get out' after a lot of averaging down over the years. This one is on the list of shares where I'm going to 'pay to see the last card turned'
substantial info available including remuneration committee report and breakdown of salaries etc
and this (as amended seemingly during 2017) apropos discussion thread
The CEO is required to build and retain a significant holding in the Company.
Under his employment agreement, as amended, Dr. Karlsson is required to invest an amount equal to £130,000 in the Company through the purchase of the Company's ordinary shares. Currently Dr. Karlsson holds 89,150 shares, as disclosed in the table below, representing an investment of £124,500. Subject to permitted trading periods
under the Company's Share Dealing Policy, it is Dr. Karlssons intention to further increase his investment in the Company.
I'd be disappointed if he only bought a further £5,500 worth out of his 2017 bonus of £254,000 (pre tax)! never mind his options
I wonder what they mean by a 'significant proportion'?
£230k is a pretty hefty bonus too when all that shareholders have seen to date is huge losses.
I'd really like to see a roadmap/timeline of how and when they expect to get this drug to market and how much if any additional capital they will need to do so.
Sir David Jack once said that this was the greatest compound he had seen in his lifetime, and yet here we are years later and still none of the big pharma's have either purchased it outright or helped to fund trials, and for the life of me, I can't understand why not, as it seems to have passed every trial to date with flying colours.
I thought the price action recently was in support of the early trial announcement scheduled for this quarter but it seems that people were buying ahead of the company financial results, which seems odd to me, what could they have possibly been expecting?
Details of the Directors emoluments for the year are set out below. An annual cash bonus is awarded on the achievement of stretch objectives that support the Companys corporate goals and business strategy together with goals in relation to personal performance. Goals typically include progress in clinical development programs, capital and cash management, pipeline development, partnering and investor relations. Jan-Anders Karlsson, CEO, was awarded a £230,000 bonus in 2016 representing 92% of target bonus against 2016 objectives.
The CEO is required to invest a significant proportion of his after-tax bonus in purchasing shares in the Company and is required to build and retain a significant holding in the Company equivalent to at least 100% of his base salary. Share option awards are made at the discretion of the Committee and are designed to encourage strong corporate performance. Awards typically vest over a three-year period. Share options granted to the CEO in 2016 vest 50% two years after the date of grant and 50% three years after the date of grant. The Committee imposes performance conditions for share options by setting the exercise price at a premium to the share price at the date of grant.
awaiting final accounts on website re breakdown of directors' remuneration and bonuses awarded - as we know J-A Karlsson is obliged to invest a substantial part thereof on the open market in our ordinary shares.
Yes I lost about £13k on xcite and a few thousands on various others but am still up overall. I know that I am extremely fortunate - I am not 'dependent' on my share portfolio being a success - it would be a nasty blow but I have other liquid assets plus a substantial index linked final salary pension from my 38 years employment and a large property in Essex. My main medium term objective is to pass on as much of my accrued wealth to my children as opposed to the taxman !!!
I'm not that far behind you in years - and will be considering same in a number of years
i hold these in my sipp along with a number of other aim shares - and perhaps i am over exposed re same as a proportion of total portfolio - or to put it another way a financial advisor might say i'm mad!
anyway it's my decision ( i don't have a financial advisor nor intend to have)
well done re griffin!
I've had more successes than failures, on aim, so far but have had one complete write off!
hurt at time (hint there) anyway
bw with your strategy and one as i noted intend to follow
Thanks mol. I think this should come good at some point but I am not prepared to put anymore funds in. This is one of my minor holdings as my large investments are in Lloyds, Griffin ( now over £1.30 and I was orig in at 3p !) TW, Saga and Sirius ( in below 4p) but now aged over 62 so want to start a slow ' cash out' programme over the next few years as each share reaches my target prices.
Not such an easy decision if u average £2.30 - could be throwing good money after bad OR as a minimum 'lending' lots more for an extended period before any return. Personally I would be happy with my stake back. Very disappointed with the speed of progress and/or absence of a major partner
Important message from the Financial Conduct Authority:
Posting inside information that is not public knowledge, or information that is false or misleading, may constitute market abuse.
This could lead to an unlimited fine and up to seven years in prison.
If you have any information, concerns or queries about market abuse, click here.
The content of the messages posted represents the opinions of the author, and does not represent the opinions of Interactive Investor Trading Limited or its affiliates and has not been approved or issued by Interactive Investor Trading Limited.
You should be aware that the other participants of the above discussion group are strangers to you and may make statements which may be misleading, deceptive or wrong.
Please remember that the value of investments or income from them may go down as well as up and that the past performance of an investment is not a guide to its performance in the future.
The discussion boards on this site are intended to be an information sharing forum and is not intended to address your particular requirements.
Whilst information provided on them can help with your investment research you need to consider carefully whether you should make (or refraining from making) investment or other decisions based on what you see without doing further research on investments you are interested in.
Participating in this forum cannot be a substitute for obtaining advice from an appropriate expert independent adviser who takes into account your circumstances and specific investment needs in selected investments that are appropriate for you.